Thromboembolic Events Following Atrial Fibrillation Cardioversion and Ablation: What's the Culprit?

Medicina (Kaunas) · 2019 · PMC6723553 · PMID 31434315

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

In patients undergoing TEE-guided cardioversion, patients on direct oral anticoagulants (DOACs), such as dabigatran and apixaban, experienced low incidence of thromboembolic events during follow-ups (0.6% and 1.1%, respectively), similar to warfarin, with a favorable trend of bleeding safety profile [ 10 , 11 ].

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.